The Apple Watch is at the center of another lawsuit as the company is facing another antitrust charge over its ECG system that it has allegedly “copied”, as per a medical firm AliveCor.
According to an AppleInsider report, the mobile medical company AliveCor has previously filed a patent infringement suit against the Cupertino based giant in Texas, US. The firm has also asked the US International Trade Commission to ban sales of the iPhone maker’s smartwatch. Now, AliveCor is also requesting a trial by jury over patent issues and has filed a lawsuit in the Northern District of California.
As per the filing, AliveCor is claiming that the smartphone manufacturer initially supported the development of an electrocardiogram wristband, the Kardiaband. The lawsuit states that “Apple not only initially approved AliveCor’s apps but also advertised AliveCor’s innovations to sell more Apple Watches. AliveCor informed Apple about [it gaining] FDA clearance and that it intended to begin selling KardiaBands shortly along with its previously-approved Kardia and SmartRhythm apps.”
The filing adds that “Apple had finally realized heart health analysis was incredibly valuable to (and desired by) smartwatch users, and thus had been working in the background to copy AliveCor’s ideas, including both the ability to record an ECG on the Apple Watch, as well as to provide a separate app for heartrate analysis.” Unfortunately, the smartphone brand has yet to comment on the new filing.
RELATED:
- Google faces yet another antitrust lawsuit in the US, this time for its advertising business
- Apple M1X Mac mini to feature thinner chassis and new iMac’s magnetic power connector: Report
- Xiaomi hopes to overtake Apple in Q2 & to emerge world’s no. 1 phone maker in 3-5 years’ time
- Facebook under antitrust probe in Turkey over updated WhatsApp terms
